Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREFER: Ferric carboxymaltose for fatigue in iron-deficient non-anaemic women
NCT01110356Phase 4Completed
- Sponsor
- CSL Vifor
- Start
- Jun 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by CSL Vifor. Started Jun 2010; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01110356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110356.